Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women with polycystic ovary syndrome: The effect of ethinyl estradiol-cyproterone acetate treatment

Gynecological Endocrinology

Volumn 17, Issue 6, 2003, Pages 441-447

  Luboshitzky, R ^a   Shen Orr, Z ^b   Herer, P ^c   Nave, R ^c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Diane 35; Hyperandrogenism; Idiopathic Hirsutism; Melatonin; Polycystic Ovary Syndrome; Testosterone

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; ANDROGEN; CYPROTERONE ACETATE; DIANE; ETHINYLESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; MELATONIN; PRASTERONE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; HYPERANDROGENISM; HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MELATONIN METABOLISM; MELATONIN SECRETION; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; REPRODUCTION; TESTOSTERONE BLOOD LEVEL; URINARY EXCRETION;

ADOLESCENT; ADRENOCORTICAL HYPERFUNCTION; ADULT; ANDROGEN ANTAGONISTS; CYPROTERONE ACETATE; DRUG THERAPY, COMBINATION; ETHINYL ESTRADIOL; FEMALE; HIRSUTISM; HUMANS; MELATONIN; POLYCYSTIC OVARY SYNDROME;

EID: 0346749652     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590312331290368     Document Type: Article

References (37)

1. Brzezinski A, Lynch HJ, Seibel NM, et al. The circadian rhythm of plasma melatonin during the normal menstrual cycle and in amenorrheic women. J Clin Endocrinol Metab 1988;66:891-5
2. Okatani Y, Sagara Y. Amplification of melatonin secretion in women with functional secondary amenorrhea: relation to endogenous oestrogen concentration. Clin Endocrinol 1994;41:766-80
3. Luboshitzky R, Lavi S, Thuma I, et al. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 1996;81:770-4
4. Kadva A, Djahanbakach O, Monson J, et al. Elevated nocturnal melatonin is a consequence of gonadotropin-releasing hormone deficiency in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 1998;83:3653-62
5. Waldhauser F, Boepple PA, Schemper M, et al. Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children. J Clin Endocrinol Metab 1991;73:793-6
6. Luboshitzky R, Wagner O, Lavi S, et al. Decreased nocturnal melatonin secretion in patients with Klinefelter's syndrome. Clin Endocrinol 1996;45:749-54
7. Voordou BGG, Euser R, Verdonk RER, et al. Melatonin and melatonin-progestin combination alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab 1992;74:108-17
8. Luboshitzky R, Shen-Orr Z, Nave R, et al. Melatonin administration alters semen quality in healthy men. J Androl 2002;23:572-8
9. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995;16:322-53
10. Poretsky L, Cataldo NA, Rosenwaks Z, et al. The insulin-related ovarian regulating system in health and disease. Endocr Rev 1999;20:535-82
11. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000;21:347-62
12. Venturoli S, Marescalchi O, Colombo FM, et al. Prospective study randomized trial comparing low-dose Flutamide, Finasteride, Ketoconazole and Cyproterone Acetate-Estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab 1999;84:1304-10
13. Mastorakos G, Koliopoulos C, Creatsas G. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril 2002;77:919-27
14. Waldhauser F, Frisch H, Krautgasser GA, et al. Serum melatonin is not affected by glucocorticoids replacement in congenital adrenal hyperplasia. Acta Endocr 1986;111:355-9
15. Blaicher W, Imhof MH, Gruber DM, et al. Endocrinological disorders focusing on melatonin interactions. Gynecol Obstet Invest 1999;48:179-82
16. Luboshitzky R, Qupti G, Ishai A, et al. Increased urinary 6-sulfatoxymelatonin excretion in women with non-classical steroid 21-hydroxylase deficiency. Neuroendocrinol Lett 2001;22:359-63
17. Luboshitzky R, Qupti G, Ishai A, et al. Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome. Fertil Steril 2001;76:506-10
18. Zitouni M, Pevet P, Masson-Pevet M. Brain and pituitary melatonin receptors in male rats during postnatal and pubertal development and the effect of pinealectomy and testosterone manipulation. J Neuroendocrinol 1996;8:571-7
19. Hernandez-Diaz FJ, Sanchez JJ, Abreu P, et al. Estrogen modulates alpha(1)/beta-adrenoreceptor-induced signaling and melatonin production in the female rat pinealocytes. Neuroendocrinology 2001;73:111-22
20. 14C-serotonin metabolism by organ cultures of male rat pineal gland. Experientia 1985;41:275-6
21. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-7
22. Falsetti L, Gaubera A, Tisi G. Efficacy of the combination of ethinyl estradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovary syndrome. Hum Reprod 2001;16:36-42
23. San Martin A, Bogdan A, Touitou Y. Day-night differences in the effects of gonadal hormones on melatonin release from perifused rat pineals. Evidence of a circadian control. Steroids 1996;61:27-32
24. Hayashi K, Okatani Y. Mechanisms underlying the effects of estrogen on nocturnal melatonin synthesis in peripubertal female rats: relation to norepinephrine and adenylate cyclase. J Pineal Res 1999;29:178-83
25. Luboshitzky R, Dharan M, Goldman D, et al. Immunohistochemical localization of gonadotropin and gonadal steroid receptors in human pineal glands. J Clin Endocrinol Metab 1997;82:977-81
26. Kruijver FP, Swaab DF. Sex hormone receptors are present in the human suprachiasmatic nucleus. Neuroendocrinology 2002;75:296-305
27. Kruijver FP, Balesar R, Espila AM, et al. Estrogen receptor-alpha distribution in the human hypothalamus in relation to sex and endocrine status. J Comp Neurol 2002;454:115-39
28. Fernandez-Gausti A, Kruijver FP, Fodor M, et al. Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol 2000;425:422-35
29. Halder-Misra C, Pevet P. The influence of luteinizing hormone-releasing hormone (LH-RH) on the process of protein and/or peptide secretion characterized by the formation of granular vesicles in mammalian pinealocytes. Cell Tissue Res 1983;232:529-38
30. Luboshitzky R, Dharan M, Goldman D, et al. Seasonal variation of gonadotropin and gonadal steroid receptors in the human pineal gland. Brain Res Bull 1997;44:665-70
31. Arendt J. The pineal in human physiology and pathology. In Arendt J, ed. Melatonin and the Mammalian Pineal Gland. London: Chapman & Hall, 1995:202-46
32. Luboshitzky R, Yanai D, Shen-Or Z, et al. Daily and seasonal variations in the concentration of melatonin in the human pineal gland. Br Res Bull 1998;47:271-6
33. Arendt J. Biochemistry of the pineal. In Arendt J, ed. Melatonin and the Mammalian Pineal Gland. London: Chapman & Hall, 1995:27-65
34. Skene DJ, Papagiannidou E, Hashemi E, et al. Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices. J Pineal Res 2001;31:333-42
35. Ursing C, Hartter S, Von Bahr C, et al. Does hepatic metabolism of melatonin affect the endogenous serum melatonin level in men? J Clin Invest 2002;25:459-62
36. Brosen K. Drug interactions and the cytochrome P450 system. The role of cytochrome P4501A2. Clin Pharamacol 1995;29:20-5
37. Shurtz EG, Brimer C, Shuetz JD. Environmental xenobiotics and the antihormone cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol Pharamacol 1998;54:1113-17